Literature DB >> 33302512

Clinical Heterogeneity in Autosomal Recessive Bestrophinopathy with Biallelic Mutations in the BEST1 Gene.

Karsten Hufendiek1,2, Katerina Hufendiek1,2, Herbert Jägle2, Heidi Stöhr3, Marius Book4, Georg Spital4, Günay Rustambayova5, Carsten Framme1, Bernhard H F Weber3,6, Agnes B Renner2,7, Ulrich Kellner8,9.   

Abstract

Autosomal recessive bestrophinopathy (ARB) has been reported as clinically heterogeneous. Eighteen patients (mean age: 22.5 years; 15 unrelated families) underwent ophthalmological examination, fundus photography, fundus autofluorescence, and optical coherence tomography (OCT). Molecular genetic testing of the BEST1 gene was conducted by the chain-terminating dideoxynucleotide Sanger methodology. Onset of symptoms (3 to 50 years of age) and best-corrected visual acuity (0.02-1.0) were highly variable. Ophthalmoscopic and retinal imaging defined five phenotypes. Phenotype I presented with single or confluent yellow lesions at the posterior pole and midperiphery, serous retinal detachment, and intraretinal cystoid spaces. In phenotype II fleck-like lesions were smaller and extended to the far periphery. Phenotype III showed a widespread continuous lesion with sharp peripheral demarcation. Single (phenotype IV) or multifocal (phenotype V) vitelliform macular dystrophy-like lesions were observed as well. Phenotypes varied within families and in two eyes of one patient. In addition, OCT detected hyperreflective foci (13/36 eyes) and choroidal excavation (11/36). Biallelic mutations were identified in each patient, six of which have not been reported so far [c.454C>T/p.(Pro152Ser), c.620T>A/p.(Leu207His), c.287_298del/p.(Gln96_Asn99del), c.199_200del/p.(Leu67Valfs*164), c.524del/p.(Ser175Thrfs*19), c.590_615del/p.(Leu197Profs*26)]. BEST1-associated ARB presents with a variable age of onset and clinical findings, that can be categorized in 5 clinical phenotypes. Hyperreflective foci and choroidal excavation frequently develop as secondary manifestations.

Entities:  

Keywords:  BEST1; autosomal recessive bestrophinopathy (ARB); bestrophin-1; fundus autofluorescence; inherited retinal dystrophy; optical coherence tomography; phenotyping

Year:  2020        PMID: 33302512      PMCID: PMC7763028          DOI: 10.3390/ijms21249353

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  43 in total

Review 1.  Focus on molecules: bestrophin (best-1).

Authors:  Alan D Marmorstein; Tyson R Kinnick
Journal:  Exp Eye Res       Date:  2006-05-23       Impact factor: 3.467

2.  Identification of the gene responsible for Best macular dystrophy.

Authors:  K Petrukhin; M J Koisti; B Bakall; W Li; G Xie; T Marknell; O Sandgren; K Forsman; G Holmgren; S Andreasson; M Vujic; A A Bergen; V McGarty-Dugan; D Figueroa; C P Austin; M L Metzker; C T Caskey; C Wadelius
Journal:  Nat Genet       Date:  1998-07       Impact factor: 38.330

3.  ISCEV Standard for full-field clinical electroretinography (2015 update).

Authors:  Daphne L McCulloch; Michael F Marmor; Mitchell G Brigell; Ruth Hamilton; Graham E Holder; Radouil Tzekov; Michael Bach
Journal:  Doc Ophthalmol       Date:  2014-12-14       Impact factor: 2.379

4.  The vitelliform macular dystrophy protein defines a new family of chloride channels.

Authors:  Hui Sun; Takashi Tsunenari; King-Wai Yau; Jeremy Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

5.  Autosomal recessive bestrophinopathy: differential diagnosis and treatment options.

Authors:  Camiel J F Boon; L Ingeborgh van den Born; Linda Visser; Jan E E Keunen; Arthur A B Bergen; Judith C Booij; Frans C Riemslag; Ralph J Florijn; Mary J van Schooneveld
Journal:  Ophthalmology       Date:  2013-01-03       Impact factor: 12.079

6.  Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration.

Authors:  F Krämer; K White; D Pauleikhoff; A Gehrig; L Passmore; A Rivera; G Rudolph; U Kellner; M Andrassi; B Lorenz; K Rohrschneider; A Blankenagel; B Jurklies; H Schilling; F Schütt; F G Holz; B H Weber
Journal:  Eur J Hum Genet       Date:  2000-04       Impact factor: 4.246

7.  Novel BEST1 gene mutations associated with two different forms of macular dystrophy in Tunisian families.

Authors:  Zohra Chibani; Imen Zone Abid; Annette Molbaek; Peter Söderkvist; Jamel Feki; Mounira Hmani-Aifa
Journal:  Clin Exp Ophthalmol       Date:  2019-07-24       Impact factor: 4.207

Review 8.  Molecular physiology of bestrophins: multifunctional membrane proteins linked to best disease and other retinopathies.

Authors:  H Criss Hartzell; Zhiqiang Qu; Kuai Yu; Qinghuan Xiao; Li-Ting Chien
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

9.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

10.  BEST1 protein stability and degradation pathways differ between autosomal dominant Best disease and autosomal recessive bestrophinopathy accounting for the distinct retinal phenotypes.

Authors:  Andrea Milenkovic; Vladimir M Milenkovic; Christian H Wetzel; Bernhard H F Weber
Journal:  Hum Mol Genet       Date:  2018-05-01       Impact factor: 6.150

View more
  3 in total

1.  First Pediatric Case of Autosomal Recessive Homozygotic Bestrophinopathy due to Homozygous Mutation c.187G>C p. in Two Brothers.

Authors:  Stefan Bittmann; Elisabeth Luchter; Gloria Villalon; Elena Moschuring-Alieva; Lara Bittmann; Anne Weissenstein
Journal:  J Clin Med Res       Date:  2022-04-12

2.  Impaired Bestrophin Channel Activity in an iPSC-RPE Model of Best Vitelliform Macular Dystrophy (BVMD) from an Early Onset Patient Carrying the P77S Dominant Mutation.

Authors:  Arnau Navinés-Ferrer; Sheila Ruiz-Nogales; Rafael Navarro; Esther Pomares
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

3.  Novel disease-causing variant in RDH12 presenting with autosomal dominant retinitis pigmentosa.

Authors:  Manickam Nick Muthiah; Angelos Kalitzeos; Kate Oprych; Navjit Singh; Michalis Georgiou; Genevieve Ann Wright; Anthony G Robson; Gavin Arno; Kamron Khan; Michel Michaelides
Journal:  Br J Ophthalmol       Date:  2021-05-24       Impact factor: 5.908

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.